|
Mankind Pharma Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
99751.34 Cr.
|
P/BV
|
9.44
|
Book Value (Rs.)
|
255.98
|
|
52 Week High/Low (Rs.)
|
3055/2115
|
FV/ML
|
1/1
|
P/E(X)
|
50.10
|
|
Bookclosure
|
08/08/2025
|
EPS (Rs.)
|
48.24
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 49.28 | 47.75 | 32.00 | 35.78 | 31.59 |
| Diluted EPS (Rs.) | 49.20 | 47.68 | 32.00 | 35.78 | 31.59 |
| Cash EPS (Rs.) | 63.50 | 58.03 | 40.52 | 40.07 | 34.96 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 347.37 | 239.04 | 190.30 | 157.68 | 121.39 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 347.37 | 239.04 | 190.30 | 157.68 | 121.39 |
| Revenue From Operations / Share (Rs.) | 295.87 | 257.99 | 218.41 | 194.25 | 155.13 |
| PBDIT / Share (Rs.) | 86.15 | 70.29 | 50.66 | 54.55 | 45.41 |
| PBIT / Share (Rs.) | 71.10 | 60.35 | 42.52 | 50.39 | 42.44 |
| PBT / Share (Rs.) | 60.69 | 59.52 | 41.41 | 48.93 | 41.94 |
| Net Profit / Share (Rs.) | 48.45 | 48.09 | 32.38 | 35.91 | 31.99 |
| NP After MI And SOA / Share (Rs.) | 48.25 | 47.75 | 32.00 | 35.78 | 31.59 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 29.11 | 27.24 | 23.19 | 28.08 | 29.27 |
| PBIT Margin (%) | 24.03 | 23.39 | 19.46 | 25.94 | 27.35 |
| PBT Margin (%) | 20.51 | 23.06 | 18.95 | 25.18 | 27.03 |
| Net Profit Margin (%) | 16.37 | 18.64 | 14.82 | 18.48 | 20.61 |
| NP After MI And SOA Margin (%) | 16.30 | 18.50 | 14.65 | 18.42 | 20.36 |
| Return on Networth / Equity (%) | 13.89 | 20.43 | 17.24 | 23.28 | 26.79 |
| Return on Capital Employeed (%) | 13.27 | 24.56 | 21.69 | 30.94 | 33.87 |
| Return On Assets (%) | 7.17 | 15.98 | 13.19 | 15.67 | 19.85 |
| Long Term Debt / Equity (X) | 0.38 | 0.00 | 0.00 | 0.01 | 0.01 |
| Total Debt / Equity (X) | 0.59 | 0.02 | 0.02 | 0.14 | 0.05 |
| Asset Turnover Ratio (%) | 0.61 | 0.95 | 0.87 | 0.98 | 1.01 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.23 | 3.10 | 2.32 | 1.68 | 2.89 |
| Quick Ratio (X) | 0.86 | 2.37 | 1.52 | 1.01 | 2.01 |
| Inventory Turnover Ratio (X) | 6.69 | 1.21 | 0.50 | 0.64 | 0.57 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 8.28 | 83.98 | 45.63 | 37.29 | 90.29 |
| Interest Coverage Ratio (Post Tax) (%) | 5.64 | 58.45 | 30.17 | 25.54 | 64.60 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 108143.49 | 91239.85 | 0.00 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 8.86 | 8.83 | 0.00 | 0.00 | 0.00 |
| EV / EBITDA (X) | 30.42 | 32.40 | 0.00 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 8.19 | 8.90 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 6.98 | 9.83 | 0.00 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 8.19 | 8.90 | 0.00 | 0.00 | 0.00 |
| EarningsYield | 0.01 | 0.02 | 0.00 | 0.00 | 0.00 |
